Conmed corporation (CNMD)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Cash flows from operating activities:
Net income

28,620

40,854

55,487

14,664

30,498

32,192

35,939

40,481

752

30,346

12,137

Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation

18,688

18,530

20,079

20,479

18,704

19,792

18,653

18,635

18,519

17,392

18,651

Amortization of debt discount

8,302

0

0

-

-

-

-

-

3,903

4,244

4,111

Amortization of deferred debt issuance costs

3,454

1,042

1,042

-

-

-

-

-

-

-

-

Amortization

53,635

42,231

37,427

34,830

25,175

25,942

29,214

27,981

20,265

20,171

18,521

Stock-based compensation

11,800

10,000

8,500

8,375

7,499

9,330

5,593

5,653

5,240

4,223

4,308

Impairment charges

312

4,212

0

0

-

-

-

-

-

-

-

Deferred income taxes

-6,310

2,063

-40,021

-2,871

2,251

-284

7,218

12,946

-13,098

13,158

4,241

Gain on sale of facility

-

-

-

1,890

0

0

-

-

-

-

-

Income tax benefit of stock option exercises

-

-

-

-

3,961

644

1,097

1,052

1,197

29,000

13,000

Income tax benefit of stock option exercises

-

-

-

-

-

-

-

-

-

227

561

Excess tax benefit from stock option exercises

-

-

-

-

4,081

922

1,518

1,206

1,363

485

886

Loss on early extinguishment of debt

-300

0

0

-

0

0

-300

0

0

-79

1,083

Impairment of goodwill

-

-

-

-

-

-

-

-

60,302

0

0

Increase (decrease) in cash flows from changes in assets and liabilities:
Accounts receivable

13,943

17,460

13,631

6,380

9,643

-5,255

798

-1,687

-8,464

-9,342

12,879

Inventories

117

15,037

3,926

-3,103

18,581

10,449

1,817

-3,810

7,850

20,317

9,454

Accounts payable

38

12,109

-286

2,094

11,508

-3,449

4,223

259

2,649

-4,645

-7,400

Income taxes

-1,867

-2,193

4,288

-200

-1,357

5,291

-1,098

-6,497

4,838

-692

-2,287

Accrued compensation and benefits

9,957

9,044

336

-2,598

-3,964

3,572

-71

767

1,673

2,516

5,630

Other assets

22,263

24,216

22,401

23,234

12,005

11,037

5,222

1,210

4,243

-332

197

Other liabilities

4,548

-6,515

18,700

-6,491

952

-10,701

-10,727

-9,159

1,745

-8,648

4,054

Total operating

-66,513

-33,847

-10,079

-25,217

-20,419

-32,984

-45,010

-54,718

-102,241

-7,897

-12,891

Net cash provided by (used in) operating activities

95,133

74,701

65,566

39,881

50,917

65,176

80,949

95,199

102,993

38,243

25,028

Cash flows from investing activities:
Proceeds from sale of a facility

-

-

-

5,178

0

0

-

1,836

0

0

-

Purchases of property, plant and equipment

20,066

16,507

12,842

14,753

15,009

15,411

18,445

21,532

17,552

14,732

21,444

Payments related to business and asset acquisitions, net of cash acquired

367,596

0

16,212

256,450

9,353

5,265

0

86,253

4,191

5,289

330

Net cash used in investing activities

-387,662

-16,507

-29,054

-266,025

-24,362

-20,676

-18,445

-105,949

-21,743

-20,021

-21,774

Cash flows from financing activities:
Net proceeds from common stock issued under employee plans

-

-

-

-

-

-

17,264

10,165

6,117

2,452

1,198

Repurchase of common stock

-

-

-

-

-

16,862

50,556

3,923

15,021

22,977

0

Excess tax benefit from stock option exercises

-

-

-

-

4,081

922

1,518

1,206

1,363

485

886

Payments on term loan

154,312

13,125

8,750

8,750

0

0

-

-

-

-

-

Payments on senior credit agreement

-

-

-

-

-

-

-

53,588

1,350

1,350

1,350

Proceeds from term loan

265,000

0

0

175,000

0

0

55,000

73,000

58,000

12,000

6,000

Payments on revolving line of credit

484,000

168,000

157,000

162,347

112,000

86,000

-

-

-

-

-

Proceeds from revolving line of credit

392,000

153,000

155,000

225,000

142,680

113,000

-

-

-

-

-

Proceeds from convertible notes

345,000

0

0

-

-

-

-

-

-

-

-

Payments related to distribution agreement

-

-

-

16,667

16,667

16,667

34,000

0

0

-

-

Payments on mortgage notes

836

1,574

1,452

1,339

1,234

1,140

1,050

969

894

824

1,425

Payments related to contingent consideration

6,466

21,323

0

0

-

-

0

-

-

-

-

Payments on senior subordinated notes

-

-

-

-

-

-

227

100

111,766

2,933

7,808

Payments related to debt issuance costs

16,210

913

0

5,556

1,485

0

1,725

0

0

2,525

0

Dividends paid on common stock

22,600

22,443

22,307

22,213

22,105

21,959

16,696

12,862

0

0

-

Purchases of convertible notes hedges

51,198

0

0

-

-

-

-

-

-

-

-

Proceeds from issuance of warrants

30,567

0

0

-

-

-

-

-

-

-

-

Other, net

3,936

2,113

-372

-585

-5,892

2,316

-824

-1,576

-3,148

66

-1,188

Net cash provided by financing activities

300,881

-72,265

-34,881

182,543

-12,622

-26,390

-31,296

11,353

-66,699

-15,606

-3,687

Effect of exchange rate changes on cash and cash equivalents

-7

-1,040

3,563

-1,475

-7,761

-6,221

-485

-2,931

-920

-297

-1,280

Net increase (decrease) in cash and cash equivalents

8,345

-15,111

5,194

-45,076

6,172

11,889

30,723

-2,328

13,631

2,319

-1,713

Non-cash investing and financing activities:
Contractual obligations from asset acquisition

5,639

8,360

0

0

-

-

-

-

-

-

-

Cash paid during the year for:
Interest Paid, Excluding Capitalized Interest, Operating Activities

27,274

19,660

16,157

13,758

5,434

5,532

5,143

5,038

5,797

6,025

6,303

Income taxes

10,576

11,048

8,869

9,588

10,261

10,206

6,837

10,953

4,760

3,257

3,650